Cargando…

Multiple BCG vaccinations for the prevention of COVID-19 and other infectious diseases in type 1 diabetes

There is a need for safe and effective platform vaccines to protect against coronavirus disease 2019 (COVID-19) and other infectious diseases. In this randomized, double-blinded, placebo-controlled phase 2/3 trial, we evaluate the safety and efficacy of a multi-dose Bacillus Calmette-Guérin (BCG) va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faustman, Denise L., Lee, Amanda, Hostetter, Emma R., Aristarkhova, Anna, Ng, Nathan C., Shpilsky, Gabriella F., Tran, Lisa, Wolfe, Grace, Takahashi, Hiroyuki, Dias, Hans F., Braley, Joan, Zheng, Hui, Schoenfeld, David A., Kühtreiber, Willem M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376308/ https://www.ncbi.nlm.nih.gov/pubmed/36027906 http://dx.doi.org/10.1016/j.xcrm.2022.100728

Ejemplares similares

THU284 BCG Clinical Trial Programs In Advanced Type 1 Diabetes - 2023 Update
por: Kühtreiber, Willem M, et al.
Publicado: (2023)

Bacillus Calmette-Guerin 's beneficial impact on glucose metabolism: evidence for broad based applications
por: Shpilsky, Gabriella F., et al.
Publicado: (2021)

BCG vaccinations drive epigenetic changes to the human T cell receptor: Restored expression in type 1 diabetes
por: Takahashi, Hiroyuki, et al.
Publicado: (2022)

BCG Vaccinations Upregulate Myc, a Central Switch for Improved Glucose Metabolism in Diabetes
por: Kühtreiber, Willem M., et al.
Publicado: (2020)

BCG therapy is associated with long-term, durable induction of Treg signature genes by epigenetic modulation
por: Keefe, Ryan C., et al.
Publicado: (2021)

SAT041 (18)F-FDG PET/CT Mapping Of Functional Microbial Niches To Understand Host Glucose Regulation After BCG Vaccinations
por: Dias, Hans, et al.
Publicado: (2023)

Bacille Calmette Guerin (BCG) and prevention of types 1 and 2 diabetes: Results of two observational studies
por: Dias, Hans F., et al.
Publicado: (2023)

THU266 Lowered HbA1c In Individuals With Long-term Type 1 Diabetes Undergoing BCG Bladder Cancer Therapy
por: Dias, Hans, et al.
Publicado: (2023)

MON-179 Repeat BCG Vaccination Creates Lasting HbA1c Reductions in Adult Subjects with Longstanding Type 1 Diabetes by Correcting Immune-Metabolic Defects
por: Faustman, Denise, et al.
Publicado: (2019)

Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations
por: Kühtreiber, Willem M., et al.
Publicado: (2018)

Strategic internal covalent cross-linking of TNF produces a stable TNF trimer with improved TNFR2 signaling
por: Ban, Liqin, et al.
Publicado: (2015)

Novel Automated Blood Separations Validate Whole Cell Biomarkers
por: Burger, Douglas E., et al.
Publicado: (2011)

The Roles of TNFR2 Signaling in Cancer Cells and the Tumor Microenvironment and the Potency of TNFR2 Targeted Therapy
por: Takahashi, Hiroyuki, et al.
Publicado: (2022)

The Diverse Applications of Recombinant BCG-Based Vaccines to Target Infectious Diseases Other Than Tuberculosis: An Overview
por: Mouhoub, Esma, et al.
Publicado: (2021)

Association of BCG Vaccine Treatment With Death and Dementia in Patients With Non–Muscle-Invasive Bladder Cancer
por: Weinberg, Marc S., et al.
Publicado: (2023)

Loss of Lipid Virulence Factors Reduces the Efficacy of the BCG Vaccine
por: Tran, Vanessa, et al.
Publicado: (2016)

BCG as a Vector for Novel Recombinant Vaccines against Infectious Diseases and Cancers
por: Mustafa, Abu Salim
Publicado: (2020)

BCG Vaccination and Tuberculosis in Japan
por: Rahman, Mahbubur, et al.
Publicado: (2007)

BCG: Disseminated BCG infection: case report
Publicado: (2022)

The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices
por: Zwerling, Alice, et al.
Publicado: (2011)

BCG Aortitis, a Rare Complication of BCG Therapy
por: Haddad, Joseph, et al.
Publicado: (2023)

Proof-of-Concept, Randomized, Controlled Clinical Trial of Bacillus-Calmette-Guerin for Treatment of Long-Term Type 1 Diabetes
por: Faustman, Denise L., et al.
Publicado: (2012)

BCG Vaccination
Publicado: (1989)

BCG Vaccination
por: Miller, Russell
Publicado: (1953)

BCG orchitis
por: Cutrone, Joseph, et al.
Publicado: (2019)

The BCG Shortage
por: Messing, Edward M.
Publicado: (2017)

Identification of Secreted O-Mannosylated Proteins From BCG and Characterization of Immunodominant Antigens BCG_0470 and BCG_0980
por: Deng, Guoying, et al.
Publicado: (2020)

Vaccination with BCGΔBCG1419c protects against pulmonary and extrapulmonary TB and is safer than BCG
por: Aceves-Sánchez, Michel de Jesús, et al.
Publicado: (2021)

The effect of Bacillus Calmette–Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic
por: Yitbarek, Kiddus, et al.
Publicado: (2020)

Multiple Consecutive Infections Might Explain the Lack of Protection by BCG
por: Cardona, Pere-Joan, et al.
Publicado: (2014)

Origins of major human infectious diseases
por: Wolfe, Nathan D., et al.
Publicado: (2007)

Recombinant BCG Overexpressing phoP-phoR Confers Enhanced Protection against Tuberculosis
por: Ahn, Sang Kyun, et al.
Publicado: (2018)

Autophagy Controls BCG-Induced Trained Immunity and the Response to Intravesical BCG Therapy for Bladder Cancer
por: Buffen, Kathrin, et al.
Publicado: (2014)

Genome sequences of BCG Pasteur ATCC 35734 and its derivative, the vaccine candidate BCGΔBCG1419c
por: D’Auria, Giuseppe, et al.
Publicado: (2023)

BCG coverage and barriers to BCG vaccination in Guinea-Bissau: an observational study
por: Thysen, Sanne Marie, et al.
Publicado: (2014)

Systemic BCG‐osis following intravesical BCG instillation for bladder carcinoma
por: Liaw, Frank, et al.
Publicado: (2017)

Evaluating the neonatal BCG vaccination programme in Ireland
por: Usher, Cara, et al.
Publicado: (2016)

BCG and Adverse Events in the Context of Leprosy
por: Richardus, Renate, et al.
Publicado: (2018)

BCG vaccine in Korea
por: Joung, Sun Myung, et al.
Publicado: (2013)

Pre-Clinical Development of BCG.HIVA(CAT), an Antibiotic-Free Selection Strain, for HIV-TB Pediatric Vaccine Vectored by Lysine Auxotroph of BCG
por: Saubi, Narcís, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_uaj61jq35r9li8nl07gasqhlot